L'Oréal-Light BioScience to develop skincare devices

13 Dec '07

2 min read

L'Oréal, the world's largest beauty company, and Light BioScience, LLC, of Virginia Beach, Virginia, leader in the medical research of LED (Light Emitting Diodes) Photomodulation have signed a scientific collaboration agreement for the development of skincare devices using Light BioScience's proprietary skin rejuvenation technology.

The agreement also provides for future worldwide marketing by L'Oréal of professional devices already developed by Light BioScience to reduce the visible signs of aging.

Light BioScience produces the GentleWaves LED Photomodulation medical device, used by physicians and medical spas around the world to reduce wrinkles and improve skin. LED Photomodulation is a non-invasive technology which stimulates the skin using low intensity LEDs. This gentle method of skin rejuvenation with light has been shown to be safe and effective and the technology is protected by numerous patents.

Jean-François Grollier, L'Oreal's Executive Vice-President Research and Development, said: "We have decided to pool our in-depth knowledge of skin and Light BioScience's unique expertise in Photomodulation to offer consumers a new and complementary approach to skincare."

With this aim in mind, L'Oréal has just created a Development Unit for instrumental cosmetics inside its Research and Development Division.

Rick Krupnick, Chief Executive Officer of Light BioScience, and David H. McDaniel MD, the physician who developed the scientific theory behind Photomodulation added, "We are very excited about this agreement: we can take advantage of the support of the world's leading cosmetics research force to jointly develop some new and highly promising applications in skin devices."

L'Oréal

More L'Oréal Group News... More Fashion News - France...